Evidence map›Paper›PMID 34552272›Full record

ArticleNature metabolism2021

Umami-induced obesity and metabolic syndrome is mediated by nucleotide degradation and uric acid generation.

Ana Andres-Hernando, Christina Cicerchi, Masanari Kuwabara, David J Orlicky, Laura Gabriela Sanchez-Lozada, Takahiko Nakagawa, Richard J Johnson, Miguel A Lanaspa

Open access · greenAbstract read
In one paragraph

Article in Nature metabolism, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 92 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Observational
  5. Article
  6. Article
  7. New Insight Into Male Infertility: Deviation From Basic Tenets of Life.Oxidative medicine and cellular longevity · 2026
    Review
  8. Article
  9. Review
  10. Article
  11. Taste Propensity in Obese and Nonobese Older Adults.Aging medicine (Milton (N.S.W)) · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Acta pharmaceutica Sinica. B · 2025
    Article
  16. Article
  17. Article
  18. Monosodium glutamate: A hidden risk factor for obesity?Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Ana Andres-Hernando *Division of Renal Diseases and Hypertension, University of Colorado School of Medicine, Aurora, CO, USA.
Christina Cicerchi *Division of Renal Diseases and Hypertension, University of Colorado School of Medicine, Aurora, CO, USA.
Masanari KuwabaraDivision of Renal Diseases and Hypertension, University of Colorado School of Medicine, Aurora, CO, USA.ORCID http://orcid.org/0000-0002-6601-4347
David J OrlickyDepartment of Pathology, University of Colorado School of Medicine, Aurora, CO, USA.ORCID http://orcid.org/0000-0002-0417-1400
Laura Gabriela Sanchez-LozadaDepartamento de Fisiopatología Cardio-Renal, National Institute of Cardiology Ignacio Chavez, Tlalpan, México.
Takahiko NakagawaDepartment of Nephrology, Rakuwakai Otowa Hospital, Kyoto, Japan.
Richard J JohnsonDivision of Renal Diseases and Hypertension, University of Colorado School of Medicine, Aurora, CO, USA.
Miguel A LanaspaDivision of Renal Diseases and Hypertension, University of Colorado School of Medicine, Aurora, CO, USA. lanaspa@ohsu.edu.ORCID http://orcid.org/0000-0002-1163-1831
University of Colorado Denver · USOregon Health & Science University · USInstituto Nacional de Cardiología · MXRakuwakai Otowa Hospital · JP

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
PILOT STUDY--SUBSTRATE METABOLISM IN EXTREMELY LOW BIRTH WEIGHT INFANTSP30DK048520 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Wendy M Kohrt · 1995 to 2026
$32.6M
Targeting fructokinase, endogenous fructose production and purine degradation for the prevention and treatment of hereditary fructose intoleranceR01DK108859 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Miguel Angel Lanaspa Garcia · 2016 to 2026
$2.4M
A Novel Role for Vasopressin in Fructose-Induced Metabolic SyndromeR01DK121496 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI LANASPA GARCIA, MIGUEL ANGEL · 2020 to 2023
$1.6M
NCI NIH HHS P30 CA046934NIDDK NIH HHS P30 DK048520NIDDK NIH HHS R01 DK108859NIDDK NIH HHS R01 DK121496
6 · The paper itself

Abstract

Umami refers to the savoury taste that is mediated by monosodium glutamate (MSG) and enhanced by inosine monophosphate and other nucleotides. Umami foods have been suggested to increase the risk for obesity and metabolic syndrome but the mechanism is not understood. Here we show that MSG induces obesity, hypothalamic inflammation and central leptin resistance in male mice through the induction of AMP deaminase 2 and purine degradation. Mice lacking AMP deaminase 2 in both hepatocytes and neurons are protected from MSG-induced metabolic syndrome. This protection can be overcome by supplementation with inosine monophosphate, most probably owing to its degradation to uric acid as the effect can be blocked with allopurinol. Thus, umami foods induce obesity and metabolic syndrome by engaging the same purine nucleotide degradation pathway that is also activated by fructose and salt consumption. We suggest that the three tastes-sweet, salt and umami-developed to encourage food intake to facilitate energy storage and survival but drive obesity and diabetes in the setting of excess intake through similar mechanisms.

Indexed as

TasteAnimalsEnergy IntakeMetabolic SyndromeMiceNucleotidesObesitySodium GlutamateUric AcidNucleotidesSodium GlutamateUric Acid

Identifiers

PMID34552272
PMCPMC9987717
OpenAlexW3200220471

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.